News from decision resources A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Oct 06, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Acquisitions Are Shaping the Dental Implant Market, Creating a Top-Heavy Competitive Landscape

 Decision Resources Group finds that the global dental implant market is becoming increasingly top-heavy as a result of a number of recent...

Oct 06, 2014, 10:00 ET

Despite Results of SYMPLICITY HTN-3, Renal Denervation Device Market is Expected to Recover

 Decision Resources Group finds that the global hypertension management device market continues to hold considerable potential, despite recent...

Oct 02, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Chronic Heart Failure Market is Set to Grow from $2.9 Billion in 2013 to $8.9 Billion in 2023, Driven Largely by the Launch of Novartis's LCZ-696

Decision Resources Group finds that the chronic heart failure (CHF) market will grow from approximately $2.9 billion in 2013 to $8.9 billion in...

Oct 02, 2014, 11:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Majority of Surveyed Nephrologists Do Not Differentiate Among Oral HIF-PH Inhibitors in Late Stage Clinical Development

 Decision Resources Group finds that approximately two-thirds of nephrologists do not differentiate among the oral hypoxia-inducible...

Oct 02, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Nurses and Physician Assistants Play a Key Role in Patient Support, Want More Patient Resources from Pharma

 Decision Resources Group finds that, as pharmas increasingly seek to differentiate their products and promote adherence through patient...

Oct 02, 2014, 10:45 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Availability of a Companion-Biomarker Test is Seen by Oncologists as a Significant Driver of Uptake of Emerging Therapies

 Decision Resources Group finds that biomarker driven prescribing is likely to positively influence perceptions of emerging drugs for both...

Oct 01, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Physicians Value Long-acting and FDC Antidiabetic Agents, Although Competitive Pricing Will Be Needed for Favorable Reimbursement

Decision Resources Group finds that the majority of surveyed endocrinologists and primary care physicians would utilize, if approved, the novel...

Sep 30, 2014, 13:32 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023

 Decision Resources Group finds that the Asia Pacific dental implant market—including Australia, China, India, Japan and South...

Sep 30, 2014, 13:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Brazilian, Russian, Indian and Chinese Markets for Peripheral Vascular Devices Will See Strong Expansion Through 2023

 Decision Resources Group finds that the markets for peripheral vascular (PV) devices in Brazil, Russia, India and China (BRIC) will see robust...

Sep 30, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents

  Decision Resources Group finds that through examination of U.S. patient-level claims data, anemic chronic kidney disease non-dialysis...

Sep 29, 2014, 14:26 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Gastric Cancer Market is Expected to More Than Triple Over the Next Ten Years, Capturing Nearly $3.8 billion by 2023

Decision Resources Group finds that the gastric cancer market will grow exponentially from over $1.1 billion in 2013 to nearly $3.8 billion by...

Sep 29, 2014, 14:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Majority of Surveyed Gastroenterologists Have a Positive Reaction to Takeda's Cell Adhesion Molecule Inhibitor Entyvio

 Decision Resources Group finds that one month post-launch, the majority of surveyed gastroenterologists are aware and familiar with Entyvio as...

Sep 25, 2014, 14:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Pharmas Are Leaving Healthcare Professionals Hanging in a Mature Mobile Market, Manhattan Research Study Finds

 Pharmas are failing to mobile optimize their websites for healthcare professionals, even as mobile devices, and particularly smartphones, have...

Sep 25, 2014, 11:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

While Physicians are Receptive to Emerging Antibiotics For Drug-Resistant Gram-Negative Infections, Payers Expect to Limit Hospital Use of Novel Premium-Priced Agents

Decision Resources Group finds that the majority of surveyed infectious diseases (ID) specialists and internists are willing to prescribe Actavis/...

Sep 23, 2014, 14:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Similarities In Key Global Markets Allow Pharma To Leverage Payer Value Messaging In Multiple Countries Through "Country Archetypes" Approach

 Decision Resources Group finds that similarities in pricing and reimbursement (P&R) decision criteria and payer requirements in key...

Sep 23, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The U.S. Surgical Navigation System Market Will Expand to $260 Million By 2023

Decision Resources Group finds that the United States market for surgical navigation systems will gradually expand due to demand for minimally...

Sep 22, 2014, 11:30 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry

Decision Resources Group finds that by the end of 2014, the Chilean pharmaceutical market is expected to be worth $2 billion (U.S. dollars),...

Sep 18, 2014, 11:15 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

At One Year Post-Launch, Approximately One Half of Surveyed U.S. Medical Oncologists Have Prescribed Single-Agent Tafinlar and Mekinist to Their Malignant Melanoma Patients

 Decision Resources Group finds that at one year post-launch in the United States, 54 percent of surveyed U.S. medical oncologists have...

Sep 18, 2014, 10:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

Regeneron's Eylea and Genentech's Lucentis Are Equally Likely to be Covered on Commercial and Medicare Advantage Plans for Wet AMD

 Decision Resources Group finds that Regeneron's Eylea, the most recently launched anti-vascular endothelial growth factor (VEGF) agent for wet...

Sep 17, 2014, 13:00 ET
Decision Resources Group Logo.  (PRNewsFoto/Decision Resources Group)

The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm

 Decision Resources Group finds that among Crohn's disease/ulcerative colitis (CD/UC) patients eligible for biologic therapy, only a proportion...